Ethological comparison of the effects of a bovine αs1-casein tryptic hydrolysate and diazepam on the behaviour of rats in two models of anxiety

Pharmacology Biochemistry and Behavior

Volumn 84, Issue 3, 2006, Pages 517-523

  Violle, Nicolas ^a   Messaoudi, Michaël ^b   Lefranc Millot, Catherine ^c   Desor, Didier ^a   Nejdi, Amine ^b   Demagny, Benoit ^c   Schroeder, Henri ^a  

^a CEMAGREF   (France)

^b CHU NANCY BRABOIS   (France)

^c INGREDIA   (France)

Author keywords

Anxiety; Bovine s1 casein tryptic hydrolysate; Conditioned defensive burying; Diazepam; Elevated plus maze; Rat; Risk taking behaviour

Indexed keywords

BENZODIAZEPINE; CASEIN; DIAZEPAM; PROTEIN HYDROLYSATE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; CONDITIONING; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; ETHOLOGY; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; RISK ASSESSMENT; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BEHAVIOR, ANIMAL; CASEINS; CATTLE; CONDITIONING, CLASSICAL; DIAZEPAM; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MAZE LEARNING; RATS; RATS, WISTAR; RISK; TRYPSIN;

BOS TAURUS;

EID: 33748204658     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2006.06.017     Document Type: Article

References (48)

1. Belzung C., and Agmo A. Naloxone potentiates the effects of subeffective doses of anxiolytic agents in mice. Eur J Pharmacol 323 (1997) 133-136
2. Bleich A., Gelkopf M., Schmidt V., Hayward R., Bodner G., and Adelson M. Correlates of benzodiazepine abuse in methadone maintenance treatment. A 1 year prospective study in an Israeli clinic. Addiction 94 (1999) 1533-1540
3. Bond A.J. Drug-induced behavioural disinhibition-incidence, mechanisms and therapeutic implications. CNS Drugs 9 (1998) 41-57
4. Calhoun S.R., Wesson D.R., Galloway G.P., and Smith D.E. Abuse of flunitrazepam (Rohypnol) and other benzodiazepines in Austin and south Texas. J Psychoact Drugs 28 (1996) 183-189
5. Chabance B., Marteau P., Rambaud J.C., Migliore-Samour D., Boynard M., Perrotin P., et al. Casein peptide release and passage to the blood in humans during digestion of milk or yogurt. Biochimie 80 (1998) 155-165
6. Chen W.I., Mi X.J., Wang R., Wang W.J., Kong W.X., Zhang Y.J., Li Y.L., et al. Behavioral effects of sinomenine in murine models of anxiety. Life Sci 78 (2005) 232-238
7. Chiba H., and Yoshikawa M. Biologically functional peptides from food proteins: new opioid peptides from milk proteins. In: Feeney R.E., and Witaker J.R. (Eds). Protein tailoring for food and medical uses (1986), Marcel Dekker Inc, New York 123-153
8. Clare D.A., Catignani G., and Swaisgood H.E. Biodefense properties of milk: the role of antimicrobial proteins and peptides. Curr Pharm Des 9 (2003) 1239-1255
9. Cosquer B., Galani R., Kuster N., and Cassel J.C. Whole-body exposure to 2.45 GHz electromagnetic fields does not alter anxiety responses in rats: a plus-maze study including test validation. Behav Brain Res 156 (2005) 65-74
10. Craft R.M., Howard J.L., and Pollard G.T. Conditioned defensive burying as a model for identifying anxiolytics. Pharmacol Biochem Behav 30 (1988) 775-780
11. Cruz A.P., Frei F., and Graeff F.G. Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol Biochem Behav 49 (1994) 171-176
12. Dawson G.R., and Trickelbank M.D. Use of the elevated plus-maze in the search for novel anxiolytic agents. Trends Pharmacol Sci 16 (1995) 33-36
13. De Boer S.F., and Koolhaas J.M. Defensive burying in rodents: ethology, neurobiology and psychopharmacology. Eur J Pharmacol 463 (2003) 145-161
14. Deakin J.B., Aitken M.R., Dowson J.H., Robbins T.W., and Sahakian B.J. Diazepam produces disinhibitory cognitive effects in male volunteers. Psychopharmacology 173 (2004) 88-97
15. Egleton R.D., Bilsky E.J., Tollin G., Dhanasekaran M., Lowery J., Alves I., et al. Biousian glycopeptides penetrate the blood-brain barrier. Tetrahedron: Asymmetry 16 (2005) 65-75
16. El Yacoubi M., Ledent C., Parmentier M., Costentin J., and Vaugeois J.M. The anxiogenic-like effect of caffeine in two experimental procedures measuring anxiety in the mouse is not shared by selective A(2A) adenosine receptor antagonists. Psychopharmacology 148 (2000) 153-163
17. Gill H.S., Doull F., Rutherfurd K.J., and Cross M.L. Immunoregulatory peptides in bovine milk. Br J Nutr 84 suppl 1 (2000) S111-S117
18. Gries D.A., Condouris G.A., Shey Z., and Houpt M. Anxiolytic-like action in mice treated with nitrous oxide and oral triazolam or diazepam. Life Sci 76 (2005) 1667-1674
19. s1-casein improves sleep in rats subjected to chronic mild stress. Peptides 27 (2006) 1476-1482
20. Kurt M., Bilge S.S., Kukula O., Celik S., and Kesim Y. Anxiolytic-like profile of propofol, a general anesthetic, in the plus-maze test in mice. Pol J Pharmacol 55 (2003) 973-977
21. Lane S.D., Tcheremissine O.V., Living L.M., Nouvion S., and Cherek D.R. Acute effects of alprazolam on risky decision making in humans. Psychopharmacology 181 (2005) 364-373
22. Lecouvey M., Frochot C., Miclo L., Orlewski P., Driou A., Linden G., et al. Two-dimensional 1H-NMR and CD structural analysis in a micellar medium of a bovine alphaS1-casein fragment having benzodiazepine-like properties. Eur J Biochem 248 (1997) 872-878
23. McDonalds S., Wells S., Giesbrecht N., and Cherpitel C.J. Demographic and substances use factors related to violent and accidental injuries: results from an emergency room study. Drug Alcohol Depend 55 (1999) 53-61
24. Meisel H., and FitzGerald R.J. Opioid peptides encrypted in intact milk protein sequences. Br J Nutr 84 suppl 1 (2000) S27-S31
25. Meisel H., and FitzGerald R.J. Biofunctional peptides from milk proteins: mineral binding and cytomodulatory effects. Curr Pharm Des 9 (2003) 1289-1295
26. Messaoudi M., Lefranc-Millot C., Desor D., Demagny B., and Bourdon L. Effects of a tryptic hydrolysate from bovine milk alphaS1-casein on hemodynamic responses in healthy human volunteers facing successive mental and physical stress situations. Eur J Nutr 44 (2005) 128-132
27. Miclo L, Perrin E, Driou A, Boudier JF, Iung C, Linden G. Use of a decapeptide with benzodiazepine activity for preparing medicines and food supplements. US patent number 5,846,939, December 8, 1998.
28. Miclo L., Perrin E., Driou A., Papadopoulos V., Boujrad N., Vanderesse R., et al. Characterization of alpha-casozepine, a tryptic peptide from bovine alpha(s1)-casein with benzodiazepine-like activity. FASEB express article (2001) 10.1096/fj.00-0685fje
29. Pellow S., Chopin P., File S.E., and Briley M. Validation of open/closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14 (1985) 149-167
30. Pihlanto-Leppala A. Bioactive peptides derived from bovine milk whey proteins: opioid and ace-inhibitory peptides. Trends Food Sci Technol 11 (2001) 347-356
31. Rodgers R.J., and Johnson J.T. Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacol Biochem Behav 52 (1995) 297-303
32. Rodgers R.J., Cutler M.G., and Jackson J.E. Behavioural effects in mice of subchronic buspirone, ondansetron and tianeptine. II. The elevated plus-maze. Pharmacol Biochem Behav 56 (1997) 295-303
33. Rodgers R.J., Cutler M.G., and Jackson J.E. Behavioural effects in mice of subchronic chlodiazepoxide, maprotiline and fluvoxamine. II. The elevated plus-maze. Pharmacol Biochem Behav 57 (1997) 127-136
34. Rutherford K.J., and Gill H.S. Peptides affecting coagulation. Br J Nutr 84 suppl 1 (2000) S99-S102
35. Sato R., Noguchi T., and Naito H. Casein phosphopeptide (CPP) enhances calcium absorption from the ligated segment of rat small intestine. J Nutr Sci Vitaminol 32 (1986) 67-76
36. Sikiric P., Jevolac N., Jelovac-Gjeldum A., Dodig G., Staresinic M., Anic T., et al. Anxiolytic effect of BPC-157, a gastric pentadecapeptide: shock probe/burying test and light/dark test. Acta Pharmacol Sin 22 (2001) 225-230
37. Silva S., and Malcata X. Caseins as source of bioactive peptides. Int Dairy J 15 (2005) 1-15
38. Silvestre J.S., Fernandez A.G., and Palacios J.M. Effects of rolipram on the elevated plus-maze test in rats: a preliminary study. Psychopharmacology 13 (1999) 274-277
39. Sipola M., Finckenberg P., Vapaatalo H., Pihlanto-Leppälä A., Korhonen H., Korpela R., et al. α-Lactorphin and β-lactorphin improve arterial function in spontaneously hypertensive rats. Life Sci 71 (2002) 1245-1253
40. Takano T. Anti-hypertensive activity of fermented dairy products containing biogenic peptides. Anton Leeuw Int J G 82 (2002) 333-340
41. Teschemacher H. Opioid receptor ligands derived from food proteins. Curr Pharm Des 9 (2003) 1331-1334
42. Treit D. Animal models for the study of anti-anxiety agents: a review. Neurosci Biobehav Rev 9 (1985) 203-222
43. Treit D., Pinel J.P., and Fibiger H.C. Conditioned defensive burying: a new paradigm for the study of anxiolytic agents. Pharmacol Biochem Behav 15 (1981) 619-626
44. Van Laar M.W., and Volkerts E.R. Driving and benzodiazepine use-evidence that they do not mix. CNS Drugs 10 (1998) 383-396
45. Varty G., Morgan C.A., Cohen-Williams M.E., Coffi V.L., and Carey G.J. The gerbil elevated Plus-maze I: behavioral characterization and pharmacological validation. Neuropsychopharmacology 27 (2002) 357-370
46. Wilson M.A., Burghardt P.R., Ford K.A., Wilkinson M.B., and Primeaux S.D. Anxiolytic effects of diazepam and ethanol in two behavioral models: comparison of males and females. Pharmacol Biochem Behav 78 (2004) 445-458
47. Zioudrou C., Streaty R.A., and Klee W. Opioid peptides derived from food proteins. The exorphins. J Biol Chem 254 (1979) 2446-2449
48. Zucht H.D., Raida M., Adermann K., Magert H.J., and Forssmann W.G. Casocidin-I: a casein-alpha s2 derived peptide exhibits antibacterial activity. FEBS Lett 372 (1995) 185-188